Literature DB >> 16321897

Rifabutin-associated panuveitis with retinal vasculitis in pulmonary tuberculosis.

Stephanie Skolik1, François Willermain, Laure E Caspers.   

Abstract

INTRODUCTION: Rifabutin-associated uveitis has been reported frequently in AIDS patients and more rarely in immunocompetent patients. It is characterized clinically by anterior acute uveitis. Only a few poorly documented cases of rifabutin-induced panuveitis with retinal vasculitis have been reported. Here, we report four cases of rifabutin-associated panuveitis with retinal vasculitis. CASE REPORTS: We describe four patients with active tuberculosis, treated with a multidrug regimen including rifabutin for at least 1.5 months before presentation. The first patient was immunocompetent, the three others had AIDS and were undergoing triple anti-HIV therapy. Three patients were women with a low body weight. All four patients presented with panuveitis and retinal vasculitis. Interruption of the drug rapidly reduced the ocular inflammation in all cases.
CONCLUSION: Four cases of rifabutin-associated panuveitis with retinal vasculitis are reported in patients with active pulmonary tuberculosis. Immunogenicity of Mycobacterium tuberculosis as well as the very low weight of the patients might be implicated in the development of this unusual form of rifabutin-associated uveitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16321897     DOI: 10.1080/09273940590951115

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  2 in total

1.  Rifabutin-associated hypopyon uveitis and retinal vasculitis with a history of acute myeloid leukemia.

Authors:  Wendy M Smith; Madhu G Reddy; Kelly A Hutcheson; Rachel J Bishop; H Nida Sen
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-02-04

2.  Drug-induced uveitis.

Authors:  Nikolas Js London; Sunir J Garg; Ramana S Moorthy; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.